2025 Georgia Life Sciences Summit Poster Session Winners

June 3, 2026 - Georgia Life Sciences is pleased to announce the promotion of Stacey Bowlin to Executive Vice President . Since joining Georgia Life Sciences in 2024, Stacey has played a central role in advancing the organization’s strategic visibility, industry partnerships, membership growth, and statewide engagement. Her leadership has helped strengthen Georgia Life Sciences’ position as a leading voice for Georgia’s biotechnology, pharmaceutical, medical device, diagnostics, and digital health sectors. “Stacey has made an extraordinary impact on Georgia Life Sciences in a very short period of time,” said Maria Thacker Goethe, President & CEO of Georgia Life Sciences . “She successfully led our transformation from Georgia Bio to Georgia Life Sciences, helping modernize our brand and better reflect the full breadth of Georgia’s life sciences industry. She has also strengthened our member recruitment and retention strategy, deepened engagement across the ecosystem, and brought a level of operational discipline that has helped position the organization for continued growth. I am thrilled to recognize Stacey’s leadership and contributions with this well-deserved promotion to Executive Vice President.” In her expanded role, Stacey will continue to lead key areas of organizational strategy, operational execution, member engagement, and long-term growth. She will work closely with the CEO to support financial and organizational performance, oversee key initiatives, and help translate Georgia Life Sciences’ long-term vision into actionable strategies that strengthen the state’s life sciences ecosystem. With more than two decades of experience in strategic engagement, marketing, operations, and industry development, Stacey brings a collaborative, mission-driven approach to leadership that aligns closely with Georgia Life Sciences’ vision for the future.

June 2, 2026, North Carolina - This week, Georgia Life Sciences' Phil Gibson joined leaders from across the engineering biology ecosystem at the Engineering Biology Research Consortium (EBRC) Annual Meeting at North Carolina State University, where he delivered a flash talk on "Advancing the Bioeconomy Industry Ecosystem." The future of the bioeconomy depends on more than breakthrough discoveries—it requires strong connections between academia, industry, and government to move innovation from the laboratory into real-world applications. At Georgia Life Sciences, we are committed to breaking down traditional silos and building pathways for collaboration among researchers, trainees, entrepreneurs, manufacturers, investors, and policymakers. By strengthening these connections, we help accelerate the translation of engineering biology innovations into new products, companies, manufacturing opportunities, and economic growth. Thank you to EBRC for convening this important conversation on the future of engineering biology and the bioeconomy.